SIVmac239感染的Mamu-B*08+印度猕猴的急性期先天性免疫反应可能有助于建立精英控制。

IF 5.7 2区 医学 Q1 IMMUNOLOGY
Frontiers in Immunology Pub Date : 2024-10-22 eCollection Date: 2024-01-01 DOI:10.3389/fimmu.2024.1478063
Brandon C Rosen, Kaitlin Sawatzki, Michael J Ricciardi, Elise Smith, Inah Golez, Jack T Mauter, Núria Pedreño-López, Aaron Yrizarry-Medina, Kim L Weisgrau, Logan J Vosler, Thomas B Voigt, Johan J Louw, Jennifer Tisoncik-Go, Leanne S Whitmore, Christakis Panayiotou, Noor Ghosh, Jessica R Furlott, Christopher L Parks, Ronald C Desrosiers, Jeffrey D Lifson, Eva G Rakasz, David I Watkins, Michael Gale
{"title":"SIVmac239感染的Mamu-B*08+印度猕猴的急性期先天性免疫反应可能有助于建立精英控制。","authors":"Brandon C Rosen, Kaitlin Sawatzki, Michael J Ricciardi, Elise Smith, Inah Golez, Jack T Mauter, Núria Pedreño-López, Aaron Yrizarry-Medina, Kim L Weisgrau, Logan J Vosler, Thomas B Voigt, Johan J Louw, Jennifer Tisoncik-Go, Leanne S Whitmore, Christakis Panayiotou, Noor Ghosh, Jessica R Furlott, Christopher L Parks, Ronald C Desrosiers, Jeffrey D Lifson, Eva G Rakasz, David I Watkins, Michael Gale","doi":"10.3389/fimmu.2024.1478063","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Spontaneous control of chronic-phase HIV/SIV viremia is often associated with the expression of specific MHC class I allotypes. HIV/SIV-specific CD8+ cytotoxic T lymphocytes (CTLs) restricted by these MHC class I allotypes appear to be critical for viremic control. Establishment of the elite controller (EC) phenotype is predictable in SIVmac239-infected Indian rhesus macaques (RMs), with approximately 50% of <i>Mamu-B*08</i>+ RMs and 20% of <i>Mamu-B*17</i>+ RMs becoming ECs. Despite extensive characterization of EC-associated CTLs in HIV/SIV-infected individuals, the precise mechanistic basis of elite control remains unknown. Because EC and non-EC viral load trajectories begin diverging by day 14 post-infection, we hypothesized that hyperacute innate immune responses may contribute to viremic control.</p><p><strong>Methods: </strong>To gain insight into the immunological factors involved in the determination of EC status, we vaccinated 16 <i>Mamu-B*08</i>+ RMs with Vif and Nef to elicit EC-associated CTLs, then subjected these 16 vaccinees and an additional 16 unvaccinated <i>Mamu-B*08</i>+ controls to repeated intrarectal SIVmac239 challenges. We then performed whole-blood transcriptomic analysis of all 32 SIVmac239-infected <i>Mamu-B*08</i>+ RMs and eight SIVmac239-infected <i>Mamu-B*08</i> <sup>-</sup> RMs during the first 14 days of infection.</p><p><strong>Results: </strong>Vaccination did not provide protection against acquisition, but peak and setpoint viremia were significantly lower in vaccinees relative to controls. We did not identify any meaningful correlations between vaccine-induced CTL parameters and SIVmac239 acquisition rate or chronic-phase viral loads. Ultimately, 13 of 16 vaccinees (81%) and 7 of 16 controls (44%) became ECs (viremia ≤ 10,000 vRNA copies/mL plasma for ≥ 4 weeks). We identified subsets of immunomodulatory genes differentially expressed (DE) between RM groupings based on vaccination status, EC status, and MHC class I genotype. These DE genes function in multiple innate immune processes, including the complement system, cytokine/chemokine signaling, pattern recognition receptors, and interferon-mediated responses.</p><p><strong>Discussion: </strong>A striking difference in the kinetics of differential gene expression among our RM groups suggests that <i>Mamu-B*08</i>-associated elite control is characterized by a robust, rapid innate immune response that quickly resolves. These findings indicate that, despite the association between MHC class I genotype and elite control, innate immune factors in hyperacute SIV infection preceding CTL response development may facilitate the establishment of the EC phenotype.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":null,"pages":null},"PeriodicalIF":5.7000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534762/pdf/","citationCount":"0","resultStr":"{\"title\":\"Acute-phase innate immune responses in SIVmac239-infected <i>Mamu-B*08+</i> Indian rhesus macaques may contribute to the establishment of elite control.\",\"authors\":\"Brandon C Rosen, Kaitlin Sawatzki, Michael J Ricciardi, Elise Smith, Inah Golez, Jack T Mauter, Núria Pedreño-López, Aaron Yrizarry-Medina, Kim L Weisgrau, Logan J Vosler, Thomas B Voigt, Johan J Louw, Jennifer Tisoncik-Go, Leanne S Whitmore, Christakis Panayiotou, Noor Ghosh, Jessica R Furlott, Christopher L Parks, Ronald C Desrosiers, Jeffrey D Lifson, Eva G Rakasz, David I Watkins, Michael Gale\",\"doi\":\"10.3389/fimmu.2024.1478063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Spontaneous control of chronic-phase HIV/SIV viremia is often associated with the expression of specific MHC class I allotypes. HIV/SIV-specific CD8+ cytotoxic T lymphocytes (CTLs) restricted by these MHC class I allotypes appear to be critical for viremic control. Establishment of the elite controller (EC) phenotype is predictable in SIVmac239-infected Indian rhesus macaques (RMs), with approximately 50% of <i>Mamu-B*08</i>+ RMs and 20% of <i>Mamu-B*17</i>+ RMs becoming ECs. Despite extensive characterization of EC-associated CTLs in HIV/SIV-infected individuals, the precise mechanistic basis of elite control remains unknown. Because EC and non-EC viral load trajectories begin diverging by day 14 post-infection, we hypothesized that hyperacute innate immune responses may contribute to viremic control.</p><p><strong>Methods: </strong>To gain insight into the immunological factors involved in the determination of EC status, we vaccinated 16 <i>Mamu-B*08</i>+ RMs with Vif and Nef to elicit EC-associated CTLs, then subjected these 16 vaccinees and an additional 16 unvaccinated <i>Mamu-B*08</i>+ controls to repeated intrarectal SIVmac239 challenges. We then performed whole-blood transcriptomic analysis of all 32 SIVmac239-infected <i>Mamu-B*08</i>+ RMs and eight SIVmac239-infected <i>Mamu-B*08</i> <sup>-</sup> RMs during the first 14 days of infection.</p><p><strong>Results: </strong>Vaccination did not provide protection against acquisition, but peak and setpoint viremia were significantly lower in vaccinees relative to controls. We did not identify any meaningful correlations between vaccine-induced CTL parameters and SIVmac239 acquisition rate or chronic-phase viral loads. Ultimately, 13 of 16 vaccinees (81%) and 7 of 16 controls (44%) became ECs (viremia ≤ 10,000 vRNA copies/mL plasma for ≥ 4 weeks). We identified subsets of immunomodulatory genes differentially expressed (DE) between RM groupings based on vaccination status, EC status, and MHC class I genotype. These DE genes function in multiple innate immune processes, including the complement system, cytokine/chemokine signaling, pattern recognition receptors, and interferon-mediated responses.</p><p><strong>Discussion: </strong>A striking difference in the kinetics of differential gene expression among our RM groups suggests that <i>Mamu-B*08</i>-associated elite control is characterized by a robust, rapid innate immune response that quickly resolves. These findings indicate that, despite the association between MHC class I genotype and elite control, innate immune factors in hyperacute SIV infection preceding CTL response development may facilitate the establishment of the EC phenotype.</p>\",\"PeriodicalId\":12622,\"journal\":{\"name\":\"Frontiers in Immunology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2024-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534762/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fimmu.2024.1478063\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2024.1478063","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言:慢性期 HIV/SIV 病毒血症的自发控制通常与特定 MHC I 类异型的表达有关。受这些MHC I类异型限制的HIV/SIV特异性CD8+细胞毒性T淋巴细胞(CTL)似乎对病毒血症的控制至关重要。在SIVmac239感染的印度猕猴(RMs)中,精英控制者(EC)表型的建立是可以预测的,大约50%的Mamu-B*08+ RMs和20%的Mamu-B*17+ RMs会成为ECs。尽管对HIV/SIV感染者中与EC相关的CTL进行了广泛表征,但精英控制的精确机制基础仍然未知。由于EC和非EC病毒载量轨迹在感染后第14天开始分化,我们假设超急性先天性免疫反应可能有助于病毒控制:为了深入了解确定EC状态所涉及的免疫学因素,我们给16个Mamu-B*08+ RM接种了Vif和Nef疫苗,以激发EC相关的CTL,然后让这16个接种者和另外16个未接种的Mamu-B*08+对照组反复接受直肠内SIVmac239挑战。然后,我们对所有 32 个感染 SIVmac239 的 Mamu-B*08+ RMs 和 8 个感染 SIVmac239 的 Mamu-B*08 - RMs 在感染的前 14 天进行了全血转录组分析:结果:接种疫苗并不能防止感染,但接种者的病毒血症峰值和设定值明显低于对照组。我们没有发现疫苗诱导的 CTL 参数与 SIVmac239 感染率或慢性期病毒载量之间存在任何有意义的相关性。最终,16 名接种者中有 13 人(81%)和 16 名对照者中有 7 人(44%)成为 EC(病毒血症≤ 10,000 vRNA 拷贝/毫升血浆,持续时间≥ 4 周)。我们根据疫苗接种状态、EC 状态和 MHC I 类基因型确定了 RM 分组之间差异表达(DE)的免疫调节基因子集。这些差异表达基因在多种先天性免疫过程中发挥作用,包括补体系统、细胞因子/趋化因子信号转导、模式识别受体和干扰素介导的反应:讨论:RM 组间差异基因表达动力学的显著差异表明,与 Mamu-B*08 相关的精英控制的特点是先天性免疫反应强健、迅速,并能很快消除。这些发现表明,尽管 MHC I 类基因型与精英控制之间存在关联,但在 CTL 反应发展之前的超急性 SIV 感染中,先天性免疫因素可能会促进 EC 表型的建立。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control.

Introduction: Spontaneous control of chronic-phase HIV/SIV viremia is often associated with the expression of specific MHC class I allotypes. HIV/SIV-specific CD8+ cytotoxic T lymphocytes (CTLs) restricted by these MHC class I allotypes appear to be critical for viremic control. Establishment of the elite controller (EC) phenotype is predictable in SIVmac239-infected Indian rhesus macaques (RMs), with approximately 50% of Mamu-B*08+ RMs and 20% of Mamu-B*17+ RMs becoming ECs. Despite extensive characterization of EC-associated CTLs in HIV/SIV-infected individuals, the precise mechanistic basis of elite control remains unknown. Because EC and non-EC viral load trajectories begin diverging by day 14 post-infection, we hypothesized that hyperacute innate immune responses may contribute to viremic control.

Methods: To gain insight into the immunological factors involved in the determination of EC status, we vaccinated 16 Mamu-B*08+ RMs with Vif and Nef to elicit EC-associated CTLs, then subjected these 16 vaccinees and an additional 16 unvaccinated Mamu-B*08+ controls to repeated intrarectal SIVmac239 challenges. We then performed whole-blood transcriptomic analysis of all 32 SIVmac239-infected Mamu-B*08+ RMs and eight SIVmac239-infected Mamu-B*08 - RMs during the first 14 days of infection.

Results: Vaccination did not provide protection against acquisition, but peak and setpoint viremia were significantly lower in vaccinees relative to controls. We did not identify any meaningful correlations between vaccine-induced CTL parameters and SIVmac239 acquisition rate or chronic-phase viral loads. Ultimately, 13 of 16 vaccinees (81%) and 7 of 16 controls (44%) became ECs (viremia ≤ 10,000 vRNA copies/mL plasma for ≥ 4 weeks). We identified subsets of immunomodulatory genes differentially expressed (DE) between RM groupings based on vaccination status, EC status, and MHC class I genotype. These DE genes function in multiple innate immune processes, including the complement system, cytokine/chemokine signaling, pattern recognition receptors, and interferon-mediated responses.

Discussion: A striking difference in the kinetics of differential gene expression among our RM groups suggests that Mamu-B*08-associated elite control is characterized by a robust, rapid innate immune response that quickly resolves. These findings indicate that, despite the association between MHC class I genotype and elite control, innate immune factors in hyperacute SIV infection preceding CTL response development may facilitate the establishment of the EC phenotype.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.80
自引率
11.00%
发文量
7153
审稿时长
14 weeks
期刊介绍: Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信